FDA Should Release Existing Supply Of Primatene Mist OTC Asthma Inhaler, Rep. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Lawmakers seek to restore the availability of Primatene Mist while the absence of an alternative OTC asthma remedy persists.
You may also be interested in...
FDA Expectation For Replacement OTC Inhaler Remains Unfulfilled
The only inhalers to treat asthma available after Dec. 31 will be prescription products.
TheraBiogen Supports Theramax Expansion With Education Push
Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: